Cardinal Health, Inc. (CAH) Dividends

Cardinal Health, Inc., incorporated on May 16, 1979, is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Company provides solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices across the world. As of June 30, 2016, the Company has manufactured or sourced approximately 2.8 billion individual consumer healthcare, home medical equipment and over-counter products, and served approximately 25,000 pharmacies.

Pharmaceutical

The Company's Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers (including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers), hospitals and other healthcare providers in the United States. It provides services to pharmaceutical manufacturers, including distribution, inventory management, data reporting, new product launch support and contract pricing and chargeback administration; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and repackages generic pharmaceuticals and over-the-counter healthcare products. The segment operates nuclear pharmacies and cyclotron facilities through its Nuclear Pharmacy Services division that manufactures, prepares and delivers radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and physician offices, and distributes specialty pharmaceutical products to hospitals and other healthcare providers. It also provides consulting, patient support and other services for specialty pharmaceutical products to pharmaceutical manufacturers and healthcare providers, and provides specialty pharmacy services through its Specialty Solutions division.

The Pharmaceutical segment is engaged in constructing a sterile facility to contract manufacture a radiopharmaceutical for prostate cancer treatment. In China, the Pharmaceutical segment distributes branded, generic and specialty pharmaceutical, over-the-counter healthcare and consumer products, provides logistics, marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Specialty Solutions division distributes oncology, rheumatology, urology, nephrology and other pharmaceutical products (specialty pharmaceutical products) and human-derived plasma products to hospitals, dialysis clinics, physician offices and other healthcare providers; provides consulting, patient support, logistics, group purchasing and other services to pharmaceutical manufacturers and healthcare providers supporting the development, marketing and distribution of specialty pharmaceutical products, and provides specialty pharmacy services.

Medical

The Medical segment distributes a range of national and Cardinal Health Brand medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States, Canada and China. It also distributes medical products to patients in the home in the United States through its Cardinal Health at Home division. This segment also manufactures, sources and develops Cardinal Health Brand medical and surgical products. Its manufactured products include single-use surgical drapes, gowns and apparel; exam and surgical gloves; fluid suction and collection systems; cardiovascular and endovascular products; wound care products, and orthopedic products. The Company, through Cordis business (Cordis), manufactures and distributes interventional cardiology devices and endovascular solutions with operations in approximately 50 countries. Its manufactured products are sold directly or through third-party distributors in the United States, Canada, Europe, Asia, Latin America and other regions internationally.

The Company, through naviHealth Holdings, LLC (naviHealth) and other companies, provides services and software to hospitals, other healthcare providers and payers that help manage the processes of patient discharge from an acute-care facility (post-acute care). This segment also assembles and offers sterile and non-sterile procedure kits. In addition, the segment provides supply chain services, including spend management, distribution management and inventory management services, to healthcare providers.

The Company competes with McKesson Corporation, AmerisourceBergen Corporation, Owens & Minor, Inc., and Medline Industries, Inc.